10 20 30 40 50 60 70 80 1GLK - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE(HEXOKINASE) 07-JUN-94 1GLK
TITLE MOLECULAR MODEL OF HUMAN BETA-CELL GLUCOKINASE BUILT BY TITLE 2 ANALOGY TO THE CRYSTAL STRUCTURE OF YEAST HEXOKINASE B
COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.1.1; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1
KEYWDS TRANSFERASE(HEXOKINASE)
EXPDTA THEORETICAL MODEL
AUTHOR R.ST.CHARLES,R.W.HARRISON,G.I.BELL,S.J.PILKIS,I.T.WEBER
REVDAT 3 01-APR-03 1GLK 1 JRNL REVDAT 2 08-MAR-95 1GLK 1 OMPND REVDAT 1 30-NOV-94 1GLK 0
JRNL AUTH R.ST CHARLES,R.W.HARRISON,G.I.BELL,S.J.PILKIS, JRNL AUTH 2 I.T.WEBER JRNL TITL MOLECULAR MODEL OF HUMAN BETA-CELL GLUCOKINASE JRNL TITL 2 BUILT BY ANALOGY TO THE CRYSTAL STRUCTURE OF YEAST JRNL TITL 3 HEXOKINASE B. JRNL REF DIABETES V. 43 784 1994 JRNL REFN ASTM DIAEAZ US ISSN 0012-1797
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1GLK COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 5 REMARK 5 THESE COORDINATES REPRESENT A MODEL OF HUMAN BETA-CELL REMARK 5 GLUCOKINASE BUILT BY ANALOGY TO A REFINED 2.1 ANGSTROM REMARK 5 CRYSTAL STRUCTURE OF YEAST HEXOKINASE B. A DETAILED REMARK 5 DESCRIPTION OF THE CONSTRUCTION OF THIS MODEL IS PRESENTED REMARK 5 IN DIABETES 43, 784 - 791, 1994. BRIEFLY, THE AMINO ACID REMARK 5 SEQUENCES OF HUMAN BETA-CELL GLUCOKINASE AND YEAST REMARK 5 HEXOKINASE B WERE OPTIMALLY ALIGNED SUCH THAT INSERTIONS REMARK 5 AND DELETIONS WERE RESTRICTED TO REGIONS BETWEEN KNOWN REMARK 5 ELEMENTS OF SECONDARY STRUCTURE IN THE YEAST HEXOKINASE REMARK 5 CRYSTAL STRUCTURE. SIDE CHAIN ATOMS FOR NON-IDENTICAL REMARK 5 RESIDUES WERE THEN REPLACED WITH THOSE OF THE CORRESPONDING REMARK 5 RESIDUES IN THE GLUCOKINASE SEQUENCE, AND MANUALLY ADJUSTED REMARK 5 WHEN NECESSARY. INSERTIONS AND DELETIONS WERE MODELLED REMARK 5 AFTER 'TEMPLATE' PEPTIDE SEGMENTS SELECTED FROM CRYSTAL REMARK 5 STRUCTURES IN THE PROTEIN DATA BANK. THE RESULTING MODEL REMARK 5 WAS THEN SUBJECTED TO STEREOCHEMICALLY-RESTRAINED ENERGY REMARK 5 MINIMIZATION USING THE PROGRAM XPLOR VERSION 3.0. THE RMS REMARK 5 DIFFERENCE IN C-ALPHA POSITIONS BETWEEN THE FINAL REMARK 5 GLUCOKINASE MODEL AND YEAST HEXOKINASE CRYSTAL STRUCTURE IS REMARK 5 0.54 ANGSTROMS. THE MODEL INCLUDES COORDINATES FOR REMARK 5 RESIDUES 8 THROUGH 465 OF HUMAN GLUCOKINASE AND A SINGLE REMARK 5 BOUND GLUCOSE MOLECULE.
REMARK 6 REMARK 6 CROSS REFERENCE TO SEQUENCE DATABASE REMARK 6 SWISS-PROT ENTRY NAME PDB ENTRY CHAIN NAME REMARK 6 HXKP_HUMAN REMARK 6 REMARK 6 THE FOLLOWING RESIDUES ARE MISSING FROM THE N-TERMINUS REMARK 6 SEQUENCE NUMBER IS THAT FROM SWISS-PROT ENTRY REMARK 6 MET 1 REMARK 6 LEU 2 REMARK 6 ASP 3 REMARK 6 ASP 4 REMARK 6 ARG 5 REMARK 6 ALA 6 REMARK 6 ARG 7
REMARK 7 REMARK 7 CORRECTION. CORRECT TYPOGRAPHICAL ERROR IN COMPND RECORD. REMARK 7 08-MAR-95.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LEU A 2 REMARK 465 ASP A 3 REMARK 465 ASP A 4 REMARK 465 ARG A 5 REMARK 465 ALA A 6 REMARK 465 ARG A 7
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 105 NE2 HIS A 105 CD2 -0.071 REMARK 500 HIS A 156 NE2 HIS A 156 CD2 -0.071 REMARK 500 HIS A 218 NE2 HIS A 218 CD2 -0.071 REMARK 500 HIS A 317 NE2 HIS A 317 CD2 -0.070 REMARK 500 HIS A 380 NE2 HIS A 380 CD2 -0.073 REMARK 500 HIS A 416 NE2 HIS A 416 CD2 -0.074 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 58 CA - CB - CG ANGL. DEV. = 16.8 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 99 -73.58 51.90 REMARK 500 LYS A 169 -96.20 62.95 REMARK 500 MET A 238 -44.05 122.67 REMARK 500 GLN A 239 -77.33 51.76 REMARK 500 VAL A 241 -37.55 58.05 REMARK 500 ASP A 344 -68.14 61.65
DBREF 1GLK A 1 465 UNP P35557 HXKP_HUMAN 1 465
SEQRES 1 A 465 MET LEU ASP ASP ARG ALA ARG MET GLU ALA ALA LYS LYS SEQRES 2 A 465 GLU LYS VAL GLU GLN ILE LEU ALA GLU PHE GLN LEU GLN SEQRES 3 A 465 GLU GLU ASP LEU LYS LYS VAL MET ARG ARG MET GLN LYS SEQRES 4 A 465 GLU MET ASP ARG GLY LEU ARG LEU GLU THR HIS GLU GLU SEQRES 5 A 465 ALA SER VAL LYS MET LEU PRO THR TYR VAL ARG SER THR SEQRES 6 A 465 PRO GLU GLY SER GLU VAL GLY ASP PHE LEU SER LEU ASP SEQRES 7 A 465 LEU GLY GLY THR ASN PHE ARG VAL MET LEU VAL LYS VAL SEQRES 8 A 465 GLY GLU GLY GLU GLU GLY GLN TRP SER VAL LYS THR LYS SEQRES 9 A 465 HIS GLN MET TYR SER ILE PRO GLU ASP ALA MET THR GLY SEQRES 10 A 465 THR ALA GLU MET LEU PHE ASP TYR ILE SER GLU CYS ILE SEQRES 11 A 465 SER ASP PHE LEU ASP LYS HIS GLN MET LYS HIS LYS LYS SEQRES 12 A 465 LEU PRO LEU GLY PHE THR PHE SER PHE PRO VAL ARG HIS SEQRES 13 A 465 GLU ASP ILE ASP LYS GLY ILE LEU LEU ASN TRP THR LYS SEQRES 14 A 465 GLY PHE LYS ALA SER GLY ALA GLU GLY ASN ASN VAL VAL SEQRES 15 A 465 GLY LEU LEU ARG ASP ALA ILE LYS ARG ARG GLY ASP PHE SEQRES 16 A 465 GLU MET ASP VAL VAL ALA MET VAL ASN ASP THR VAL ALA SEQRES 17 A 465 THR MET ILE SER CYS TYR TYR GLU ASP HIS GLN CYS GLU SEQRES 18 A 465 VAL GLY MET ILE VAL GLY THR GLY CYS ASN ALA CYS TYR SEQRES 19 A 465 MET GLU GLU MET GLN ASN VAL GLU LEU VAL GLU GLY ASP SEQRES 20 A 465 GLU GLY ARG MET CYS VAL ASN THR GLU TRP GLY ALA PHE SEQRES 21 A 465 GLY ASP SER GLY GLU LEU ASP GLU PHE LEU LEU GLU TYR SEQRES 22 A 465 ASP ARG LEU VAL ASP GLU SER SER ALA ASN PRO GLY GLN SEQRES 23 A 465 GLN LEU TYR GLU LYS LEU ILE GLY GLY LYS TYR MET GLY SEQRES 24 A 465 GLU LEU VAL ARG LEU VAL LEU LEU ARG LEU VAL ASP GLU SEQRES 25 A 465 ASN LEU LEU PHE HIS GLY GLU ALA SER GLU GLN LEU ARG SEQRES 26 A 465 THR ARG GLY ALA PHE GLU THR ARG PHE VAL SER GLN VAL SEQRES 27 A 465 GLU SER ASP THR GLY ASP ARG LYS GLN ILE TYR ASN ILE SEQRES 28 A 465 LEU SER THR LEU GLY LEU ARG PRO SER THR THR ASP CYS SEQRES 29 A 465 ASP ILE VAL ARG ARG ALA CYS GLU SER VAL SER THR ARG SEQRES 30 A 465 ALA ALA HIS MET CYS SER ALA GLY LEU ALA GLY VAL ILE SEQRES 31 A 465 ASN ARG MET ARG GLU SER ARG SER GLU ASP VAL MET ARG SEQRES 32 A 465 ILE THR VAL GLY VAL ASP GLY SER VAL TYR LYS LEU HIS SEQRES 33 A 465 PRO SER PHE LYS GLU ARG PHE HIS ALA SER VAL ARG ARG SEQRES 34 A 465 LEU THR PRO SER CYS GLU ILE THR PHE ILE GLU SER GLU SEQRES 35 A 465 GLU GLY SER GLY ARG GLY ALA ALA LEU VAL SER ALA VAL SEQRES 36 A 465 ALA CYS LYS LYS ALA CYS MET LEU GLY GLN
HET GLC 466 24
HETNAM GLC GLUCOSE
FORMUL 2 GLC C6 H12 O6
HELIX 1 1 GLU A 9 GLN A 24 1 16 HELIX 2 2 GLN A 26 LEU A 45 1 20 HELIX 3 3 PRO A 111 THR A 116 1 6 HELIX 4 4 THR A 118 LYS A 136 1 19 HELIX 5 5 VAL A 181 ARG A 191 1 11 HELIX 6 6 ASN A 204 ASP A 217 1 14 HELIX 7 7 LEU A 271 SER A 281 1 11 HELIX 8 8 GLN A 287 GLY A 294 1 8 HELIX 9 9 GLY A 294 GLU A 312 1 19 HELIX 10 10 SER A 321 THR A 326 1 6 HELIX 11 11 GLU A 331 SER A 340 1 10 HELIX 12 12 ASP A 344 GLY A 356 1 13 HELIX 13 13 SER A 360 ARG A 397 1 38 HELIX 14 14 GLY A 410 HIS A 416 1 7 HELIX 15 15 SER A 418 THR A 431 1 14 HELIX 16 16 GLY A 446 MET A 462 1 17
SHEET 1 A 6 LEU A 58 PRO A 59 0 SHEET 2 A 6 MET A 251 ASN A 254 -1 N ASN A 254 O LEU A 58 SHEET 3 A 6 CYS A 230 GLU A 236 -1 O TYR A 234 N VAL A 253 SHEET 4 A 6 CYS A 220 VAL A 226 -1 O GLU A 221 N MET A 235 SHEET 5 A 6 THR A 405 ASP A 409 1 O THR A 405 N GLU A 221 SHEET 6 A 6 THR A 437 GLU A 440 1 O THR A 437 N VAL A 406 SHEET 1 B 5 VAL A 101 SER A 109 0 SHEET 2 B 5 ASN A 83 VAL A 91 -1 N PHE A 84 O TYR A 108 SHEET 3 B 5 GLY A 72 LEU A 79 -1 O GLY A 72 N VAL A 91 SHEET 4 B 5 LEU A 144 THR A 149 1 O PRO A 145 N LEU A 75 SHEET 5 B 5 MET A 197 VAL A 203 1 O ASP A 198 N LEU A 146 SHEET 1 C 3 VAL A 154 HIS A 156 0 SHEET 2 C 3 GLY A 162 LEU A 164 -1 O ILE A 163 N ARG A 155 SHEET 3 C 3 ASN A 179 ASN A 180 -1 O ASN A 179 N LEU A 164
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000